Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$420M |
| 2 |
Zoom
ZM
|
+$370M |
| 3 |
Uber
UBER
|
+$267M |
| 4 |
Intel
INTC
|
+$247M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$143M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$421M |
| 2 |
AbbVie
ABBV
|
+$266M |
| 3 |
Amgen
AMGN
|
+$212M |
| 4 |
PPLI
People Inc
PPLI
|
+$207M |
| 5 |
Eli Lilly
LLY
|
+$100M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.49% |
| 2 | Healthcare | 14.08% |
| 3 | Financials | 12.39% |
| 4 | Consumer Discretionary | 12.01% |
| 5 | Communication Services | 9.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ROCC
2626
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $3.26M | ﹤0.01% |
330,810
-4,713
| -1% | -$50K |
|
|
CALA
2627
DELISTED
Calithera Biosciences, Inc
CALA
| $3.25M | ﹤0.01% |
47,185
+3,050
| +7% | +$266K |
|
2628
Greif Class B
GEF.B
$4.21B
| $3.25M | ﹤0.01% |
82,397
+384
| +0.5% | +$15.9K |
|
2629
Hurco Companies Inc
HURC
$143M
| $3.25M | ﹤0.01% |
114,263
-199
| -0.2% | -$5.77K |
|
2630
Sutro Biopharma
STRO
$421M
| $3.22M | ﹤0.01% |
32,048
+5,816
| +22% | +$549K |
|
|
REVG
2631
DELISTED
REV Group
REVG
| $3.21M | ﹤0.01% |
407,151
+8,436
| +2% | +$60K |
|
2632
Aprea Therapeutics
APRE
$8.05M
| $3.21M | ﹤0.01% |
6,667
+1,359
| +26% | +$761K |
|
|
CTO
2633
CTO Realty Growth
CTO
$815M
| $3.2M | ﹤0.01% |
267,444
+1,363
| +0.5% | +$15.2K |
|
|
PRTK
2634
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $3.19M | ﹤0.01% |
590,647
+4,540
| +0.8% | +$22.5K |
|
|
EIGR
2635
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $3.19M | ﹤0.01% |
13,046
+1,374
| +12% | +$427K |
|
2636
MediciNova
MNOV
$66M
| $3.18M | ﹤0.01% |
607,216
+17,323
| +3% | +$99.9K |
|
|
IHC
2637
DELISTED
Independence Holding Company
IHC
| $3.17M | ﹤0.01% |
84,214
-3,948
| -4% | -$137K |
|
2638
Clearfield
CLFD
$374M
| $3.17M | ﹤0.01% |
157,158
+15,557
| +11% | +$279K |
|
2639
Old Second Bancorp
OSBC
$1.29B
| $3.16M | ﹤0.01% |
422,017
+9,777
| +2% | +$78.2K |
|
|
RVI
2640
DELISTED
Retail Value Inc. Common Shares
RVI
| $3.16M | ﹤0.01% |
2,739,423
+89,509
| +3% | +$103K |
|
|
AGRX
2641
DELISTED
Agile Therapeutics
AGRX
| $3.15M | ﹤0.01% |
518
+13
| +3% | +$74.5K |
|
2642
Citizens & Northern Corp
CZNC
$455M
| $3.14M | ﹤0.01% |
193,467
+794
| +0.4% | +$14K |
|
2643
Liquidity Services
LQDT
$1.32B
| $3.13M | ﹤0.01% |
419,539
+25,574
| +6% | +$168K |
|
|
PLYM
2644
DELISTED
Plymouth Industrial REIT
PLYM
| $3.12M | ﹤0.01% |
252,947
+34,108
| +16% | +$446K |
|
2645
Clear Channel Outdoor Holdings
CCO
$1.23B
| $3.11M | ﹤0.01% |
3,110,738
+208,872
| +7% | +$224K |
|
|
SCU
2646
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $3.11M | ﹤0.01% |
264,982
-438
| -0.2% | -$5.63K |
|
|
PCSB
2647
DELISTED
PCSB Financial Corporation
PCSB
| $3.1M | ﹤0.01% |
256,965
+785
| +0.3% | +$9.65K |
|
|
TRVN
2648
DELISTED
Trevena, Inc.
TRVN
| $3.1M | ﹤0.01% |
1,657
+554
| +50% | +$730K |
|
2649
Greenlight Captial
GLRE
$506M
| $3.09M | ﹤0.01% |
459,836
+11,531
| +3% | +$79.2K |
|
|
ONT
2650
Onterris Inc
ONT
$580M
| $3.09M | ﹤0.01% |
+129,841
| New | +$3.3M |
|
Similar funds
Geode Capital Management's Q3 2020 Portfolio in Review
As of Q3 2020, Geode Capital Management held 4,244 positions worth $510B, up 9.2% from $467B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2020 filing shows 144 new, 2,112 increased, 1,496 reduced and 90 closed positions. Its largest new stake was Snowflake: 195,170 shares worth $48.9M. The largest sale was Apple, an estimated $421M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q3 2020 buy was Snowflake: 195,170 shares worth $48.9M.
- Geode Capital Management added most to Amazon in Q3 2020, an estimated $420M increase.
- Geode Capital Management's biggest Q3 2020 reduction was Apple, cutting an estimated $421M.
- Geode Capital Management fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $84.5M.
- Geode Capital Management's ten largest holdings make up 23% of its $510B portfolio in Q3 2020.
- Geode Capital Management opened 144 new positions and closed 90 in Q3 2020.
- Geode Capital Management's portfolio value rose 9.2% quarter-over-quarter to $510B.
Based on Geode Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.